Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a small update to the page version.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3. This change reflects a newer build of the page content rather than a substantive modification.SummaryDifference0.0%

- Check38 days agoChange DetectedThe study page now indicates it is no longer recruiting participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, while the Intervention/Treatment header was renamed from Intervention / Treatment and the revision label updated to v3.6.0.SummaryDifference0.3%

- Check45 days agoChange DetectedThe study plan now includes a new Sample Collection section added on 2026-06-02 as part of revision 3.5.5, superseding revision 3.5.4.SummaryDifference0.2%

- Check59 days agoChange DetectedGainesville site name was updated from University of Florida Health Science Center - Gainesville to UF Health Cancer Institute - Gainesville, and new entries for Diagnostic CAT Scan Service Type and Diagnostic CAT Scan were added to the imaging services.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page metadata or formatting; the change does not modify the study details or primary content.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.